Literature DB >> 2973380

Lymphocyte immunophenotyping of B-cell lymphomas: a flow cytometric analysis of neoplastic and nonneoplastic cells in 271 cases.

R M de Martini1, R R Turner, D C Boone, R J Lukes, J W Parker.   

Abstract

We have reviewed our experience with 271 B-cell lymphomas to determine the effectiveness of flow cytometry in the characterization of these malignancies. Flow cytometric immunophenotyping of the total lymphocyte and/or large lymphocyte populations confirmed the morphologic diagnosis of B-cell lymphoma in 92% of cases, which included 79% monoclonal and 13% surface immunoglobulin (SIg)-negative lymphomas. Light chain monoclonality was most frequent in low grade and follicular center cell (FCC) lymphomas, while SIg-negative cases were most common in high grade and non-FCC types. Low grade lymphomas of all histologic types had high median percentages of neoplastic cells and low T-cell percentages. Conversely, high grade lymphomas exhibited lower and less uniform median percentages of B-cells, with higher numbers of T-cells and lower CD4/CD8 ratios than low grade lymphomas. Several differences in B- and T-cells were observed between specific high grade histologic types. FCC lymphomas with a diffuse pattern had lower percentages of CD4+ cells and lower CD4/CD8 ratios than cases with a follicular pattern. Thus, immunophenotypic differences were observed between histologic types or groups with known differences in clinical course and prognosis. We conclude that flow cytometry provides reliable information on neoplastic and nonneoplastic cells in lymph nodes involved by B-cell lymphomas.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2973380     DOI: 10.1016/0090-1229(88)90126-2

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  8 in total

1.  Multiparametric immunophenotyping of B cells in peripheral blood of healthy adults by flow cytometry.

Authors:  H G Höffkes; G Schmidtke; M Uppenkamp; U Schmücker
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

2.  Parotid gland follicular lymphoma lacking both cytoplasmic and surface light chains: a rare case.

Authors:  Jenny Smith; Fang Wen; Jeffrey Cao; Xiangdong Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

3.  A comparative study of frozen-section immunoperoxidase and flow cytometry for immunophenotypic analysis of lymph node biopsies.

Authors:  K W Biesemier; G A Dent; K B Pryzwansky; J D Folds
Journal:  Clin Diagn Lab Immunol       Date:  1994-05

4.  Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas.

Authors:  Lisa M Rimsza; William A Day; Sarah McGinn; Anne Pedata; Yasodha Natkunam; Roger Warnke; James R Cook; Teresa Marafioti; Thomas M Grogan
Journal:  Diagn Pathol       Date:  2014-07-21       Impact factor: 2.644

5.  Inconclusive flow cytometric surface light chain results; can cytoplasmic light chains, Bcl-2 expression and PCR clonality analysis improve accuracy of cytological diagnoses in B-cell lymphomas?

Authors:  Andreja Brozic; Ziva Pohar Marinsek; Srdjan Novakovic; Veronika Kloboves Prevodnik
Journal:  Diagn Pathol       Date:  2015-10-20       Impact factor: 2.644

Review 6.  Cytologic and Molecular Diagnostics for Vitreoretinal Lymphoma: Current Approaches and Emerging Single-Cell Analyses.

Authors:  Wei Jian Tan; Mona Meng Wang; Paola Ricciardi-Castagnoli; Anita Sook Yee Chan; Tong Seng Lim
Journal:  Front Mol Biosci       Date:  2021-01-11

7.  Aptamer Internalization via Endocytosis Inducing S-Phase Arrest and Priming Maver-1 Lymphoma Cells for Cytarabine Chemotherapy.

Authors:  Huan Li; Shuanghui Yang; Ge Yu; Liangfang Shen; Jia Fan; Ling Xu; Hedong Zhang; Nianxi Zhao; Zihua Zeng; Tony Hu; Jianguo Wen; Youli Zu
Journal:  Theranostics       Date:  2017-03-06       Impact factor: 11.556

Review 8.  Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies.

Authors:  Shuanghui Yang; Huan Li; Ling Xu; Zhenhan Deng; Wei Han; Yanting Liu; Wenqi Jiang; Youli Zu
Journal:  Mol Ther Nucleic Acids       Date:  2018-09-06       Impact factor: 8.886

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.